معرفی
Remy Francisca is a researcher in the Department of Internal Medicine at Erasmus MC, focusing on drug safety, pharmacoepidemiology, and regulatory aspects of medicine and medical device surveillance in the European Union. Their work is closely aligned with the European Medicines Agency (EMA) and involves extensive collaboration with European research networks such as ENCePP.
Their research interests span pharmacoepidemiology, systematic reviews, meta-analyses, cohort and observational studies, and risk management across the life cycle of medicines. A significant portion of their work evaluates additional risk minimisation measures and medication errors in centrally authorised products, contributing to regulatory science and patient safety.
The publication trends show a consistent focus on regulatory frameworks, post-authorization safety studies, and risk evaluation mechanisms in the EU. Their research integrates epidemiological methods with health policy, emphasizing evidence-based approaches to drug and device safety monitoring.
Remy Francisca has not received any explicitly mentioned scientific awards. However, their research has garnered significant attention, with over 160 readers on Mendeley and engagement across social media platforms including X (formerly Twitter) and Facebook.
There is no information available regarding grant funding or student supervision. Remy Francisca has not advised any named students based on the provided data.
Their research is conducted within collaborative networks involving Erasmus MC and European institutions, particularly in the context of ENCePP and EMA-related studies. While no specific lab or research team is named, their work is deeply embedded in multi-institutional, data-driven projects focused on improving post-market safety surveillance.
حوزههای پژوهشی
